Dr Daniel Chapple

Commercial Director

Dr Daniel Chapple

Daniel is an experienced commercial leader with more than 25 years in the life sciences sector, spanning clinical research, patient engagement, healthcare technology and consultancy. As Commercial Director at Richmond Pharmacology, he leads the organisation's commercial strategy, overseeing business development, account management, proposals, contracts and marketing.  

Combining a strong scientific background with extensive commercial expertise across both full-service and specialist CRO’s, he has helped organisations strengthen sponsor partnerships, drive growth and expand access to high-quality clinical research services.  

Daniel holds a PhD from Guy's Hospital, London, and remains actively involved in academia as a visiting lecturer and research supervisor at King's College London. He is also a member of a Health Research Authority (HRA) Research Ethics Committee (REC), bringing valuable insight into patient engagement and the ethical delivery of clinical research.  

At Richmond, Daniel is focused on building strategic partnerships, enhancing the sponsor experience and supporting the continued growth of the organisation's clinical trial capabilities.

‍

Latest news

The Future of Cardiometabolic Research: Five Questions Shaping the Next Decade

October 22, 2026
Cardiometabolic research is continually evolving beyond explanations centred on single causes of disease.
Read more

Upcoming Event

AASLD

05 - 09 November 2026
Richmond Pharmacology is excited to join the AASLD Emerging Topic Conference: Unified Frontiers in Liver Disease in Denver, USA, on 05– 09 November 2026.
View event